Company Profile
Immunic Stock Price, News & Analysis
- Ticker:
- IMUX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Germany
Stock performance
13.81 USD (+3.14%)
Close
Last updated: July 27, 2026
199M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, IMUX closed up 3.14% at $13.81. No new same-company headline was identified in the current news window.
Company overview
Business overview
Immunic is a biotechnology company focused on immune-mediated disease and small-molecule immunology. Its pipeline is aimed at inflammatory and autoimmune disorders.
Geographic Base and Sector Classification
Headquartered in Germany and listed on NASDAQ as an ADR, Immunic has a global specialty-biopharma profile.
Business Model Characteristics
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation franchise.
Position Within the Biotechnology Landscape
Immunic is a catalyst-sensitive immunology name whose stock reacts to early clinical and mechanistic signals.
Future catalysts
Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly. The market still needs a stronger human-data story.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
AVTX · Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Immunic (IMUX)?
Immunic (IMUX) most recently closed at 13.81 USD, a +3.14% move versus the previous session.
What is the market cap of Immunic (IMUX)?
Immunic currently has a market capitalization of 199M USD on BioPharmSignal.
What does Immunic do?
Immunic is a biotechnology company focused on immune-mediated disease and small-molecule immunology. Its pipeline is aimed at inflammatory and autoimmune disorders.
On which exchange is IMUX stock listed?
Immunic (IMUX) is associated with NASDAQ, Germany, Biopharma.
What is Immunic?
Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly.
Which conditions is Immunic targeting with Immunic?
Immunic is associated with immunology, inflammatory disease based on its company overview and current catalyst commentary.
How does Immunic describe recent progress with Immunic?
Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly.
What future catalysts are investors watching for Immunic?
Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly. The market still needs a stronger human-data story.